The first prospective study to look at this problem since investigators identified an issue earlier confirmed that clinicians ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

Amer, S.A.A., Elzarrug, H.K.H.A. and Elfakhri, A.A. (2025) Sociodemographic and Clinical Characteristics of Participants Attended Glaucoma Screening Week in Benghazi 2023. Open Access Library Journal, ...